199 related articles for article (PubMed ID: 11100730)
21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
22. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
23. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
24. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
Masel J; Genoud N; Aguzzi A
J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
[TBL] [Abstract][Full Text] [Related]
25. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
26. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
Fujihara A; Atarashi R; Fuse T; Ubagai K; Nakagaki T; Yamaguchi N; Ishibashi D; Katamine S; Nishida N
FEBS J; 2009 May; 276(10):2841-8. PubMed ID: 19459939
[TBL] [Abstract][Full Text] [Related]
27. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
28. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
29. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
[TBL] [Abstract][Full Text] [Related]
30. Synthetic fibril peptide promotes clearance of scrapie prion protein by lysosomal degradation.
Okemoto-Nakamura Y; Yamakawa Y; Hanada K; Tanaka K; Miura M; Tanida I; Nishijima M; Hagiwara K
Microbiol Immunol; 2008 Jul; 52(7):357-65. PubMed ID: 18667034
[TBL] [Abstract][Full Text] [Related]
31. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
32. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of prion disease progression: a chemical reaction network approach.
Méndez JM; Femat R
IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
[TBL] [Abstract][Full Text] [Related]
34. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
35. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
36. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
37. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
38. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
39. An improved method for cell-to-cell transmission of infectious prion.
Tanaka M; Hara H; Nishina H; Hanada K; Hagiwara K; Maehama T
Biochem Biophys Res Commun; 2010 Jul; 397(3):505-8. PubMed ID: 20515650
[TBL] [Abstract][Full Text] [Related]
40. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
Benvegnù S; Poggiolini I; Legname G
J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
